Non-Hodgkin’s lymphoma in a hemophilic patient with a traumatic hematoma by Nihal Özdemir et al.
237 Letter to the Editor  
Non-Hodgkin’s lymphoma in a hemophilic patient 
with a traumatic hematoma
Travmatik hematomu olan hemofilik hastada non-Hodgkin lenfoma
Nihal Özdemir1, Ayşe Yurt1, Emine Türkan2, Tiraje Celkan1
1Department of Pediatric Hematology, Cerrahpaşa Faculty of Medicine, İstanbul University, İstanbul, Turkey
2Department of Pediatric Hematology Oncology, Okmeydanı State Hospital, İstanbul, Turkey
Address for Correspondence: Dr. Nihal Özdemir, Department of Pediatric Hematology, Cerrahpaşa Faculty of Medicine, İstanbul 
University, İstanbul, Turkey Phone: +90 212 414 30 00 E-mail: gnozdemir@hotmail.com
doi:10.5152/tjh.2011.62
To the editor,
Hemophilia A, the most common severe inherited 
bleeding disorder, is characterized by FVIII deficiency. 
The use of recombinant FVIII products and improved 
purity of plasma-derived concentrates have decreased 
the risk of HIV, and hepatitis B and C virus transmis-
sion in patients with hemophilia. Malignancies report-
ed in hemophilic patients are usually associated with 
HIV, and hepatitis B and C infection. The incidence of 
non-infection-related malignancy is not known due 
to the limited quantity of data in the literature [1]. 
Herein we report a boy with hemophilia A that was 
followed-up  with  the  initial  diagnosis  of  a  neck 
hematoma; examination of a subsequent excisional 
biopsy specimen resulted in the diagnosis of non-
Hodgkin’s lymphoma (NHL).
A 12-year-old boy with mild hemophilia A (FVIII 
coagulant activity 7%; vWF Ag: 78%; Ricof: 72%) had 
been followed-up at another center since he was 5 
years  old.  Six  months  before  presentation  at  our 
institution  the  patient  had  a  tooth  extracted  and 
developed a mass in the neck. Initially, a muscle 
hematoma was suspected. As the mass enlarged, 
needle  aspiration  was  performed,  and  the  result 
showed  reactive  hyperplasia.  The  patient  was 
referred to our clinic for further investigation. 
The  patient  did  not  have  symptoms  suggesting 
lymphoma or any other malignancy. Physical exami-
nation was normal, except for a 2×1.5-cm soft mass 
in  the  neck.  Full  blood  count,  peripheral  blood 
smear,  sedimentation  rate  (7  mm/h),  and  lactate 
dehydrogenase  (LDH:  184  IU/L)  were  normal. 
Cervical magnetic resonance imaging (MRI) showed 
a  heterogenous  solid  mass  between  the  subman-
dibular  gland  and  sternocleidomastoid  muscle. 
Thoracic  and  abdominal  computed  tomography 
(CT) results were normal. Positron emission tomog-
raphy (PET) showed hypermetabolic lymphadenop-
athies in the left inferior cervical and supraclavicular 
fossa.  Excisional  biopsy  under  factor  replacement 
showed T cell-rich diffuse B cell NHL. There was no 
bone  marrow  or  cerebrospinal  fluid  involvement, 
and he was classified as stage 2 NHL. Viral serology, 
including  HIV,  and  hepatitis  B  and  C  viruses  was 
negative. The patient was treated according to the 
BFM-NHL 95 protocol and did not have any severe 
bleeding episodes during chemotherapy. Moreover, 
no  complications  occurred  during  cerebrospinal 
fluid  tap  or  bone  marrow  aspiration/biopsy. Cerebrospinal fluid tap was performed 4 times by 
an experienced hematologist every time, and FVIII 
infusion and fresh frozen plasma were not adminis-
tered. At the end of therapy, PET-CT was normal 
and the patient has been in remission for 1 year, as 
of the time this report was written.
Most  malignancies  in  hemophilic  patients  are 
related to HIV and hepatitis infections due to con-
taminated blood products. Walker and Julian ana-
lyzed the cause of death in Canadians with hemo-
philia  between  1980  and  1995,  and  reported  a 
marked increase in deaths from liver cancer and 
lymphoma in patients with HCV or HIV infections, 
as compared to the general population [2]. A study 
performed in the UK between 1978 and 1999 with a 
hemophilic  population  reported  67  NHL  cases  in 
HIV-positive  patients  [3],  whereas  the  incidence 
was much lower in HIV-negative individuals only 9 
cases.  The  number  of  cases  of  NHL  among  HIV-
negative hemophilic patients was equal to the num-
ber  of  cases  expected  in  the  general  population. 
There are also reports of HIV-negative patients with 
Hodgkin’s lymphoma [4,5].
Hemophilia may influence the clinical presenta-
tion and diagnostic evaluation of malignancies. As 
the presented case had hemophilia and a history of 
trauma, there was a delay in the diagnosis of lym-
phoma. A similar case with severe hemophilia and 
Hodgkin’s disease also highlights the importance of 
clinical awareness when the signs and symptoms of 
a presumed hematoma do not resolve with time [5]. 
There are also case reports of patients with hemo-
philia that were eventually diagnosed with soft tissue 
sarcomas that mimicked pseudotumors [6]. 
Another important issue is the difficulty in treat-
ment caused by the coexistence of bleeding diathe-
sis and malignancy. Specific clinical problems may 
emerge  during  chemotherapy  in  patients  with 
hemophilia and cancer, which may be challenging 
for physicians. The inherent tendency for bleeding 
may  increase  the  probability  of  bleeding  due  to 
thrombocytopenia  caused  by  chemotherapy. 
Invasive procedures, such as bone marrow biopsy 
or catheter replacement, may require factor replace-
ment. Chemotherapy-induced cytopenia, mucosal 
toxicity, and hemostatic disturbances may be more 
problematic than expected. There are only few case 
reports on the management of leukemia in hemo-
philic patients [7-9]. A study of 2 patients by Zulfikar 
reported the existence of social and psychological 
burden associated with the coexistence of 2 difficult 
diseases, such as acute leukemia and severe hemo-
philia, among patients and families [7]. Based on 
our experience managing such cases, we recom-
mend regular and adequate factor replacement in 
order to minimize the risk of bleeding during treat-
ment. As the presented case had mild hemophilia, 
there were no major problems during his treatment.
In  conclusion,  the  management  of  cancer  in 
hemophilic patients is challenging. Consideration of 
probable malignancy in the differential diagnosis of 
patients with hemophilia and posttraumatic hema-
toma is critical. Additional research on the manage-
ment of hemophilic patients with cancer may result 
in  improved  treatment  options.  Written  informed 
consent was obtained from the patient. 
Conflict of interest statement
The  authors  of  this  paper  have  no  conflicts  of 
interest, including specific financial interests, rela-
tionships, and/or affiliations relevant to the subject 
matter or materials included.
References
1.  Dunn AL. Malignancy in patients with hemophilia: a 
review of the literature. Hemophilia 2010;16:427-36.
2.  Walker  IR,  Julian  JA.  Causes  of  death  in  Canadians 
with hemophilia 1980-1995. Association of Hemophilia 
Clinic Directors of Canada. Hemophilia 1998;4:714-20.
3.  Wilde JT, Lee CA, Darby SC, Kan SW, Giangrande P , 
Phillips  AN,  Winter  M,  Spooner  R,  Ludlam  CA;  UK 
Haemophilia  Centre  Doctors'  Organisation.  The  inci-
dence of lymphoma in the UK hemophilia population 
between 1978 and 1999. AIDS 2002;16:1803-7.
4.  Koç A, Varan A, Büyükpamukçu M, Gürgey A. A case of 
hemophilia A associated with Hodgkin's disease. Turk 
J Pediatr 1999;41:517-20.
5.  Smith R, Marson B, Smith M, Rangarajan S. Incidental 
finding of Hodgkin's disease following initial presenta-
tion with traumatic haematoma in the thoracic inlet. 
Hemophilia 2008;14:610-2.
6.  Connor P , Cheung B, Rangarajan S. Malignant sarcoma 
masquerading  as  a  pseudotumour  in  a  patient  with 
mild hemophilia. Br J Haematol 2003;123:191.
7.  Zulfikar  B.  Two  patients  with  hemophilia  and  acute 
leukaemia. Hemophilia 2002;8:698-702.
8.  Altay C, Hicsonmez G, Zamani VP , Sagin G, Tuncer M, 
Ozsoylu S. Acute leukemia in two patients with hemo-
philia. Cancer 1985;55:510-1.
9.  Clark C, Gidvani VK. Acute myelogenous leukemia in a 
patient  with  a  severe  factor  IX  deficiency.  Pediatr 
Blood and Cancer 2011;56:156-7.
Özdemir et al.
Hemophilia and non-Hodgkin’s lymphoma Turk J Hematol 2011; 28: 237-8 238